Published on 1/10/2014 in the Prospect News Structured Products Daily.
New Issue: UBS prices $183,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
New York, Jan. 10 - UBS AG, London Branch priced $183,000 of 9.49% annualized airbag yield optimization notes due July 15 linked to the common stock of Vertex Pharmaceuticals Inc., according to a 424B2 filing with the Securities and Exchange Commission.
Interest is payable monthly.
The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Vertex Pharmaceuticals shares equal to $1,000 divided by the conversion price. The conversion price is 60% of the initial share price.
UBS Financial Services Inc. and UBS Investment Bank is the agent.
Issuer: | UBS AG, London Branch
|
Issue: | Airbag yield optimization notes
|
Underlying stock: | Vertex Pharmaceuticals Inc.
|
Amount: | $183,000
|
Maturity: | July 15
|
Coupon: | 9.49% annualized, payable monthly
|
Price: | Par
|
Payout at maturity: | If final share price is less than conversion price, number of Vertex Pharmaceuticals shares equal to $1,000 divided by conversion price; otherwise, par
|
Initial share price: | $78.21
|
Conversion price: | $46.93, 60% of initial price
|
Pricing date: | Jan. 10
|
Settlement date: | Jan. 15
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 1%
|
Cusip: | 90272A885
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.